Zimmer Biomet Holdings Inc (ZBH)
110.22
+1.82
(+1.68%)
USD |
NYSE |
Nov 22, 16:00
110.30
+0.08
(+0.07%)
After-Hours: 20:00
Zimmer Biomet Holdings Cash from Investing (Quarterly): -154.90M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -154.90M |
| June 30, 2024 | -247.00M |
| March 31, 2024 | -195.00M |
| December 31, 2023 | -220.80M |
| September 30, 2023 | -165.60M |
| June 30, 2023 | -243.10M |
| March 31, 2023 | -149.40M |
| December 31, 2022 | -112.50M |
| September 30, 2022 | -85.20M |
| June 30, 2022 | -243.20M |
| March 31, 2022 | -88.30M |
| December 31, 2021 | -146.20M |
| September 30, 2021 | -125.20M |
| June 30, 2021 | -109.90M |
| March 31, 2021 | -122.30M |
| December 31, 2020 | -315.90M |
| September 30, 2020 | -91.40M |
| June 30, 2020 | -85.30M |
| March 31, 2020 | -121.20M |
| December 31, 2019 | -138.00M |
| September 30, 2019 | -163.60M |
| June 30, 2019 | -322.20M |
| March 31, 2019 | -105.50M |
| December 31, 2018 | -82.40M |
| September 30, 2018 | -138.90M |
| Date | Value |
|---|---|
| June 30, 2018 | -93.60M |
| March 31, 2018 | -101.70M |
| December 31, 2017 | -128.20M |
| September 30, 2017 | -120.50M |
| June 30, 2017 | -129.00M |
| March 31, 2017 | -133.10M |
| December 31, 2016 | -146.80M |
| September 30, 2016 | -1.374B |
| June 30, 2016 | -266.20M |
| March 31, 2016 | 95.80M |
| December 31, 2015 | 68.70M |
| September 30, 2015 | 94.10M |
| June 30, 2015 | -7.789B |
| March 31, 2015 | 67.90M |
| December 31, 2014 | 28.70M |
| September 30, 2014 | -229.40M |
| June 30, 2014 | -170.30M |
| March 31, 2014 | -98.40M |
| December 31, 2013 | -10.20M |
| September 30, 2013 | -150.70M |
| June 30, 2013 | -174.60M |
| March 31, 2013 | 53.00M |
| December 31, 2012 | -224.60M |
| September 30, 2012 | -85.40M |
| June 30, 2012 | -117.90M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-315.90M
Minimum
Dec 2020
-85.20M
Maximum
Sep 2022
-158.02M
Average
-142.10M
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -2.172B |
| Boston Scientific Corp | -1.427B |
| NeuroOne Medical Technologies Corp | -0.0148M |
| SINTX Technologies Inc | -0.031M |
| Nutriband Inc | -0.0389M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 395.70M |
| Cash from Financing (Quarterly) | -101.90M |
| Free Cash Flow | 1.259B |
| Free Cash Flow Per Share (Quarterly) | 1.816 |
| Free Cash Flow to Equity (Quarterly) | -369.20M |
| Free Cash Flow to Firm (Quarterly) | 427.36M |
| Free Cash Flow Yield | 5.54% |